<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01642784</url>
  </required_header>
  <id_info>
    <org_study_id>2.0, 2011-11-24</org_study_id>
    <nct_id>NCT01642784</nct_id>
  </id_info>
  <brief_title>Complete Infarct Related Artery Revascularization in Acute Myocardial Infarction</brief_title>
  <acronym>CORAMIreg</acronym>
  <official_title>Complete Infarct Related Artery Revascularization in Acute Myocardial Infarction Registry(CORAMIreg)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundacja Ośrodek Badań Medycznych</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundacja Ośrodek Badań Medycznych</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objective of this registry study is to compare strategy of complete vs. target lesion-only
      primary PCI (percutaneous coronary intervention) in IRA (infarct related artery) in STEMI (ST
      elevation myocardial infarction) patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      CORAMI is a registry study addressing the issue of complete vs culprit-only PCI within
      infarct related artery in patients with ST-elevation and non-ST elevation myocardial
      infarction treated with interventional procedures.

      The main objectives of the study include:

        1. gathering data on patients with at least two independent critical stenotic lesions in
           IRA (one of which is the culprit lesion) during index primary PCI for STEMI or NSTEMI
           (prevalence, characteristic, predisposing factors).

        2. comparing chosen treatment strategies for multiple lesion IRA

        3. comparison of complete vs. target lesion-only PCI in IRA in acute MI (myocardial
           infarction) patients.

      The study clinical hypothesis is that stenting single critical - culprit lesion in
      multi-lesion IRA in MI patients during index PCI procedure is superior to stenting all
      critical lesions in IRA in terms of early treatment result and might be associated with less
      frequent periprocedural angiographic complications.

      H0: The efficacy in terms of early treatment result of stenting one critical - culprit lesion
      in multilesions IRA in acute MI patients is less or equal to efficacy of stenting all
      critical lesions in IRA.

      H1: The efficacy in terms of early treatment result of stenting one critical - culprit lesion
      in multilesions IRA in acute MI patients is greater than efficacy of stenting all critical
      lesions in IRA.

      CORAMI Registry is a prospective, international (Poland, Slovenia), multicenter observational
      study with retrospective chart review which will be performed in experienced invasive
      facility centres with 24/7 PCI duty and continuous patient enrollment for 18 months (January
      2011 - June 2012).

      This study will collect data on all consecutive patients with STEMI and NSTEMI undergoing
      immediate coronary angiography which demonstrated at least two independent (requiring two
      stent platforms) critical lesions in infarct related artery (one of which is considered as
      target/culprit lesion that have caused the myocardial infarction and requires immediate PCI).
      Patients will be treated (multiple or single lesion stenting) according to local standard and
      operator's decision. Patient follow up phone call and/or visit (according to local protocols)
      will be performed at 12 months from enrollment if applicable by local standards.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Actual">July 2013</completion_date>
  <primary_completion_date type="Actual">July 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Death</measure>
    <time_frame>At 12 months</time_frame>
    <description>Death rates at 12-month clinical follow-up</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stent thrombosis</measure>
    <time_frame>At 12 months</time_frame>
    <description>Rates of stent thrombosis at 12-month follow-up according to ARC definition</description>
  </primary_outcome>
  <primary_outcome>
    <measure>reMI (repeat myocardial infarctions)</measure>
    <time_frame>At 12 months</time_frame>
    <description>Rates of reMI at 12 months</description>
  </primary_outcome>
  <primary_outcome>
    <measure>urgent TVR (target vessel revascularization) at 12 months</measure>
    <time_frame>12 months and at 12 months</time_frame>
    <description>Rates of urgent TVR at 12 months</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Planned TVR</measure>
    <time_frame>At 12 months</time_frame>
    <description>Rates of planned TVR (PCI + CABG) at 12 months</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Angiographic complications</measure>
    <time_frame>During hospitalization</time_frame>
    <description>Immediate in-hospital angiographic complications (at least one or more of the following: distal embolisation, no-reflow, slow-flow, acute coronary artery occlusion, artery perforation, tamponade, dissection type B and above)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target Vessel Revascularization (PCI and/or CABG (coronary artery bypass graft))</measure>
    <time_frame>During hospitalization and at 12 months</time_frame>
    <description>Urgent in-hospital Target Vessel Revascularization (PCI and/or CABG)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complete contrast dose in ml</measure>
    <time_frame>During hospitalization and at 12 months</time_frame>
    <description>Complete contrast dose in ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complete radiation dose in mGy</measure>
    <time_frame>During hospitalization and at 12 months</time_frame>
    <description>Complete radiation dose in mGy</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">100</enrollment>
  <condition>Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>Culprit lesion IRA revascularization</arm_group_label>
    <description>Culprit lesion IRA revascularization</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Complete IRA revascularization</arm_group_label>
    <description>Complete IRA revascularization</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Primary PCI of culprit lesion in IRA with drug eluting stent (DES)</intervention_name>
    <description>Primary PCI of culprit lesion in IRA with drug eluting stent (DES)</description>
    <arm_group_label>Culprit lesion IRA revascularization</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Primary PCI of culprit lesion in IRA with drug eluting stent (DES) and PCI of the other critical lesion in IRA with another DES</intervention_name>
    <description>Primary PCI of culprit lesion in IRA with drug eluting stent (DES) and PCI of the other critical lesion in IRA with another DES</description>
    <arm_group_label>Complete IRA revascularization</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Study population will comprise of approx. 200 patients (males and females) with the
        diagnosis of STEMI or NSTEMI and at least two independent critical lesions in infarct
        related artery (one of which is considered as target/culprit lesion that have caused the
        myocardial infarction and requires immediate PCI). Patients enrolled to the registry must
        meet all the eligibility criteria.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of STEMI or NSTEMI (according to ESC 2007 definition)

          -  Over 18 years of age

          -  Presence of two critical lesions requiring PCI in IRA (LAD (left anterior descending),
             Cx (circumflex), RCA (right coronary artery)):

               1. Target/culprit lesion which requires immediate stenting (&gt;50 - 100%) and

               2. Second critical lesion (70-90%).

        Exclusion Criteria:

          -  Terminal illness with life expectancy less &lt;1 year or active cancer disease,

          -  Pregnancy or possibility of pregnancy

          -  Second critical lesion in IRA &gt;90% or occlusion

          -  Contraindications to PCI or/and stent implantation

          -  Con-current participation in another clinical study that did not meet its primary
             end-point
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bogdan Januś, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pracownia Hemodynamiki Szpital im. E. Szczeklika</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Krakowskie centrum Kardiologii Inwazyjnej, Elektroterapii i Angiologii, Carint Scanmed Sp. z o.o.</name>
      <address>
        <city>Kraków</city>
        <zip>30-693</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centrum Kardiologii Inwazyjnej GVM Carint</name>
      <address>
        <city>Ostrowiec Swietokrzyski</city>
        <zip>27-400</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centrum Kardiologii Inwazyjnej GVM Carint</name>
      <address>
        <city>Oświecim</city>
        <zip>32-600</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oddział Kardiologii Inwazyjnej, Elektroterapii i Angiologii w Pińczowie</name>
      <address>
        <city>Pinczow</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Podkarpackie Centrum Interwencji Sercowo -Naczyniowych NZOZ</name>
      <address>
        <city>Sanok</city>
        <zip>38-500</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pracownia Hemodynamiki Szpital im. E. Szczeklika</name>
      <address>
        <city>Tarnów</city>
        <zip>33-100</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>I Katedra i Klinika Kardiologii, Warszawski Uniwersytet Medyczny</name>
      <address>
        <city>Warszawa</city>
        <zip>02-097</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Departament of Cardiology, University Hospital, Ljubljana</name>
      <address>
        <city>Ljubljana</city>
        <country>Slovenia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
    <country>Slovenia</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 25, 2012</study_first_submitted>
  <study_first_submitted_qc>July 15, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 17, 2012</study_first_posted>
  <last_update_submitted>July 2, 2013</last_update_submitted>
  <last_update_submitted_qc>July 2, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 3, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>STEMI</keyword>
  <keyword>NSTEMI</keyword>
  <keyword>revascularization</keyword>
  <keyword>stents</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

